Pulmatrix (PULM) EBIT Margin (2014 - 2024)
Pulmatrix (PULM) reported EBIT Margin of -65066.67% for Q4 2024, down 64965.62 percentage points from -101.04% a year earlier and down 64340.71 percentage points from the prior quarter.
Powered by 
Analysis
Pulmatrix (PULM) EBIT Margin (2014 - 2024) Analysis & Trends
For FY2024, Pulmatrix posted EBIT Margin of -125.07%, up 76.90 percentage points from FY2023.
- EBIT Margin has increased for three consecutive years, with a five-year change of +136.52 percentage points (FY2019 to FY2024).
- By year, EBIT Margin came in at -201.97% in FY2023 (+110.12 pp), -312.09% in FY2022 (+78.06 pp), -390.15% in FY2021 (-312.09 pp) and -78.06% in FY2020 (+183.53 pp).
- The Q4 2024 figure ranks as the lowest quarterly EBIT Margin in data going back to Q1 2014.
- Year over year, EBIT Margin has now declined in each of the last three quarters, with an average year-over-year change of -8108.02 percentage points over the last eight quarters.
- The high point for year-over-year EBIT Margin in five years was Q4 2022 (a gain of 633.40 percentage points); the low point was Q4 2024 (a drop of 64965.62 percentage points).
- Per Business Quant data, the three quarters before Q4 2024 came in at -725.96% (Q3 2024), -380.22% (Q2 2024) and 12.69% (Q1 2024).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 28.21% |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 37.86% |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | -3.52% |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 32.97% |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 20.57% |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 34.95% |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | -133.21% |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 28.37% |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 37.40% |
| 10 | Pulmatrix | 5.55 Mn | 5.55 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2024 | -65,066.67% |
| Sep 30, 2024 | -725.96% |
| Jun 30, 2024 | -380.22% |
| Mar 31, 2024 | 12.69% |
| Dec 31, 2023 | -101.04% |
| Sep 30, 2023 | -224.70% |
| Jun 30, 2023 | -216.43% |
| Mar 31, 2023 | -305.87% |
| Dec 31, 2022 | -253.22% |
| Sep 30, 2022 | -272.44% |
| Jun 30, 2022 | -342.52% |
| Mar 31, 2022 | -427.84% |
| Dec 31, 2021 | -886.62% |
| Sep 30, 2021 | -766.14% |
| Jun 30, 2021 | -170.76% |
| Mar 31, 2021 | -293.88% |
| Dec 31, 2020 | -133.70% |
| Sep 30, 2020 | -29.21% |
| Jun 30, 2020 | -33.54% |
| Mar 31, 2020 | -171.51% |
API Access
Pulmatrix EBIT Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebit-margin&ticker=PULM&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebit-margin", "ticker": "PULM", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebit-margin&ticker=PULM&period=max&api_key=YOUR_API_KEY");
const data = await res.json();